Sammartano, V. et al. 2025. Efficacy and safety of teclistamab followed by autologous stem cells transplant in functional high-risk and triple class refractory multiple myeloma. Mediterranean Journal of Hematology and Infectious Diseases. 17, 1 (Jun. 2025), e2025051. DOI:https://doi.org/10.4084/MJHID.2025.051.